Increasing life expectancy, technological advances and demand for new drugs are presenting opportunities in healthcare, writes Peter Askew, co-manager of the T. Bailey Growth fund
‘Die another day' would perhaps be an apt heading for this piece. Not because it is a critique of an old Bond film, rather a reflection on how we are all living longer and the implications that has for healthcare, savings and, not least, investment opportunities. Life expectancy continues to rise in the UK and around most of the globe. It is a meaningful demographic trend and one that alters individuals' concepts of retirement and lifestyle. According to research published in the Lancet in March, life expectancy in the UK has increased by 4.2 years to 79.9 years since 1990. By the end...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
